This Core now supports basic, translational and clinical research. The Flow Cytometry and Immune Monitoring Core Facility has been broadened to include an immune monitoring component to provide stateof- the-art technologies for cellular and serum analysis available to Cancer Center investigators with interest in basic science or clinical applications. Since the last submission the Flow Cytometry component has acquired two new state-of-the-art instruments: a dual laser high speed digital cell sorter and a dual laser analyzer. With this instrumentation the Core is able to accommodate the increasing applications that investigators request. The personnel managing this facility have served Cancer Center members for over 20 years. In the last year the Facility was utilized by 32 different Cancer Center members that represent an increase of 60% over the previous grant submission. These investigators accounted for 88% of the Facilities total usage. The new Immune Monitoring component offers services to investigators engaged in clinical immunotherapy trials. These include cancer vaccines or cytokines, or clinical trials in which the immune status of the patient might provide predictive or diagnostic information. An example of the latter is cytokine levels that might be linked to a disease outcome. In addition, this component will also assist preclinical researchers that want to analyze immune responses in animal (tumor) models. The services include the current standard for immune monitoring: the ELISPOT assay for detection of cytokines released by activated T cells, intracellular cytokine staining, enumeration of T cells by tetramer analysis, a multiplex assay for detection of up to 13 cytokines as well as radioisotope-based proliferation and cytotoxicity assays. Another critical service the core provides is the standardized isolation of serum and cells from (apheresed) blood specimens and freezing and storing the cells for later analyses. Both components are evaluated by a common User Committee. The Immune Monitoring facility is being set up with a $1M investment in equipment, maintenance contracts and pilot research projects through the Mabel and Arnold Beckman Foundation. No support for the Immune Monitoring component is requested until year 2 when the Beckman foundation grant expires.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Southern California
Los Angeles
United States
Zip Code
Basso, Virginia; Garcia, Angie; Tran, Dat Q et al. (2018) Fungicidal Potency and Mechanisms of ?-Defensins against Multidrug-Resistant Candida Species. Antimicrob Agents Chemother 62:
Neumeyer, Sonja; Banbury, Barbara L; Arndt, Volker et al. (2018) Mendelian randomisation study of age at menarche and age at menopause and the risk of colorectal cancer. Br J Cancer 118:1639-1647
Ning, Y; Zhang, W; Hanna, D L et al. (2018) Clinical relevance of EMT and stem-like gene expression in circulating tumor cells of metastatic colorectal cancer patients. Pharmacogenomics J 18:29-34
Austria, Theresa; Marion, Christine; Yu, Vanessa et al. (2018) Mechanism of cytokinesis failure in ovarian cystadenomas with defective BRCA1 and P53 pathways. Int J Cancer 143:2932-2942
Eriguchi, Yoshihiro; Nakamura, Kiminori; Yokoi, Yuki et al. (2018) Essential role of IFN-? in T cell-associated intestinal inflammation. JCI Insight 3:
Battaglin, Francesca; Naseem, Madiha; Puccini, Alberto et al. (2018) Molecular biomarkers in gastro-esophageal cancer: recent developments, current trends and future directions. Cancer Cell Int 18:99
Zhang, Junjie; Zhao, Jun; Xu, Simin et al. (2018) Species-Specific Deamidation of cGAS by Herpes Simplex Virus UL37 Protein Facilitates Viral Replication. Cell Host Microbe 24:234-248.e5
Suenaga, Mitsukuni; Schirripa, Marta; Cao, Shu et al. (2018) Gene Polymorphisms in the CCL5/CCR5 Pathway as a Genetic Biomarker for Outcome and Hand-Foot Skin Reaction in Metastatic Colorectal Cancer Patients Treated With Regorafenib. Clin Colorectal Cancer 17:e395-e414
Thomas, Nancy E; Edmiston, Sharon N; Orlow, Irene et al. (2018) Inherited Genetic Variants Associated with Melanoma BRAF/NRAS Subtypes. J Invest Dermatol 138:2398-2404
Cobo, Eduardo R; Holani, Ravi; Moreau, France et al. (2018) Entamoeba histolytica Alters ileal Paneth Cell Functions in Intact and Muc2 Mucin Deficiency. Infect Immun :

Showing the most recent 10 out of 842 publications